• 04.04.19

    FCA Cases: Convincing DOJ to Move to Dismiss

    Manatt’s Jacqueline Wolff, a partner in the investigations and white collar defense group, wrote for Law Journal Newsletters on treatment of cases related to the False Claims Act under Attorney General William Barr.

  • 10.01.18

    Are Allegations of Lack of Medical Necessity in False Claims Act Cases a Basis for Settlement or ...

    Health care fraud and False Claims Act cases continue to generate a significant source of funds for the Federal Government.

  • 06.18.18

    New York Attorney General’s Cartel Bust Is Just the Beginning

    Earlier this year, the New York attorney general’s office brought two separate criminal actions against local firms and associated individuals for antitrust violations ...

  • 04.01.18

    America’s Opioid Crisis

    "The nation’s opioid epidemic claimed more than 42,000 lives in 2016, and experts fear it will get worse before it gets better. What can be done to combat this multifaceted threat to public health? This article looks at how the crisis began, reviews how four sectors have responded and ...

  • 02.01.18

    The National Opioid Epidemic: The Emergence of a Multi-Layered Approach

    On Oct. 26, 2017, Eric D. Hargan, acting secretary of the Department of Health and Human Services, announced that, as a result of the opioid epidemic, “a public health emergency exists nationwide.” According to the CDC, from 1999 to 2016, more than 200,000 people died in the United ...

  • 11.20.17

    Winds of Change at the DOJ for Corporate Prosecutions?

    On Sept. 14, 2017, Deputy Attorney General Rod Rosenstein indicated during a Q&A session that “there may be some change to the policy on corporate prosecutions” in the works at the DOJ.

  • 11.20.17

    Spotlight on the False Claims Act—Kickbacks for Opiates Edition

    On Sept. 8, 2017, the DOJ announced that a pharmaceutical company agreed to pay $7.55 million to resolve allegations that it violated the False Claims Act by paying doctors kickbacks to prescribe a “highly addictive” opiate-based drug.

  • 10.18.17

    FCPA and Healthcare: The DOJ’s New Bedfellows

    In a speech on July 25, 2017, Sandra Moser, acting chief of the Fraud Section of the Department of Justice (DOJ), announced that prosecutors from the agency’s Foreign Corrupt Practices Act (FCPA) Unit would henceforth be “working hand in hand” with the Corporate Strike ...

  • 10.18.17

    Criminal Charges, Civil Fines for Bitcoin Exchange and Operator

    On July 26, 2017, the Department of Justice (DOJ) announced that a grand jury in the Northern District of California had indicted the digital currency exchange BTC-e and the Russian national behind it for operating an unlicensed money service business and money laundering.

  • 07.31.17

    Spotlight on the False Claims Act

    Since our last newsletter, the DOJ has announced numerous resolutions under the False Claims Act with companies in the healthcare and other business sectors, but the one that caught our eye involved a large vendor of electronics